The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation

Molecular and Cellular Biology

Volumn 20, Issue 2, 2000, Pages 516-522

  Monsonego Ornan, E ^a   Adar, R ^a   Feferman, T ^b   Segev, O ^a   Yayon, A ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b ProChon Biotech Ltd   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; DIMERIZATION; DOWN REGULATION; GENE CONTROL; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH PLATE; HUMAN; HUMAN CELL; INTERNALIZATION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL;

AMINO ACID SUBSTITUTION; ANIMALS; BONE DEVELOPMENT; CELL LINE; CELL MEMBRANE; CHONDROCYTES; DIMERIZATION; DOWN-REGULATION; ENDOCYTOSIS; GROWTH PLATE; HUMANS; KINETICS; LIGANDS; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR WEIGHT; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR AGGREGATION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION;

ANIMALIA; MUS MUSCULUS;

EID: 0033981302     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.2.516-522.2000     Document Type: Article

References (42)

1. Basilico, C., and D. Moscatelli. 1992. The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59:115-165.
2. Bellus, G. A., I. McIntosh, J. Szabo, A. Aylsworth, I. Kaitila, and C. A. Francomano. 1996. Hypochondroplasia: molecular analysis of the fibroblast growth factor receptor 3 gene. Ann. N. Y. Acad. Sci. 785:182-187.
3. Cancedda, R., F. Descalzi Cancedda, and P. Castagnola. 1995. Chondrocyte differentiation. Int. Rev. Cytol. 159:265-358.
4. Coffin, J. D., R. Z. Florkiewicz, J. Neumann, T. Mort-Hopkins, G. W. Dorn II, P. Lightfoot, R. German, P. N. Howles, A. Kier, B. A. O'Toole, et al. 1995. Abnormal hune growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol. Biol. Cell 6:1861-1873.
5. Colvin, J. S., B. A. Bohne, G. W. Harding, D. G. McEwen, and D. M. Ornitz. 1996. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet. 12:390-397.
6. Delezoide, A. L., C. Lasselin-Benoist, L. Legeai-Mallet, P. Brice, V. Senee, A. Yayon, A. Munnich, M. Vekemans, and J. Bonaventure. 1997. Abnormal FGFR 3 expression in cartilage of thanatophoric dysplasia fetuses. Hum. Mol. Genet. 6:1899-1906.
7. Deng, C., B. A. Wynshaw, F. Zhou, A. Kuo, and P. Leder. 1996. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84:911-921.
8. Givol, D., and A. Yayon. 1992. Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J. 6:3362-3369.
9. Grigoriadis, A. E., J. N. Heersche, and J. E. Aubin. 1988. Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone. J. Cell Biol. 106: 2139-2151.
10. Horton, W. A., M. A. Machado, J. Ellard, D. Campbell, E. A. Putnam, A. L. Aulthouse, X. Sun, and L. J. Sandell. 1993. An experimental model of human chondrocyte differentiation. Prog. Clin. Biol. Res. 3838:533-540.
11. Jingushi, S., S. P. Scully, M. E. Joyce, Y. Sugioka, and M. E. Bolander. 1995. Transforming growth factor-beta 1 and fibroblast growth factors in rat growth plate. J. Orthop. Res. 13:761-768.
12. Johnson, D. E., and L. T. Williams. 1993. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60:1-41.
13. Keegan, K., S. Meyer, and M. J. Hayman. 1991. Structural and biosynthetic characterization of the fibroblast growth factor receptor 3 (FGFR-3) protein. Oncogene 6:2229-2236.
14. Leach, R. J., C. Sokol, and J. P. McMurtry. 1997. Immunolocalization of basic fibroblast growth factor in porcine epiphyseal growth plate. Domest. Anim. Endocrinol. 14:129-132.
15. Li, Y., K. Mangasarian, A. Mansukhani, and C. Basilico. 1997. Activation of FGF receptors by mutations in the transmembrane domain. Oncogene 14: 1397-1406.
16. McConahey, P. J., and F. J. Dixon. 1980. Radioiodination of proteins by the use of the chloramine-T method. Methods Enzymol. 70:210-213.
17. McDougall, S., Y. H. Fu, G. N. Lowe, A. Williams, R. Polendo, P. D. Benya, A. Iida-Klein, M. A. Fang, and T. J. Hahn. 1996. Surface adhesion-mediated regulation of chondrocyte-specific gene expression in the nontransformed RCJ 3.1C5.18 rat chondrocyte cell line. J. Bone Miner. Res. 11:1130-1138.
18. Naski, M. C., Q. Wang, J. Xu, and D. M. Ornitz. 1996. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat. Genet. 13:233-237.
19. Nilsson, A., C. Ohlsson, O. G. Isaksson, A. Lindahl, and J. Isgaard. 1994. Hormonal regulation of longitudinal bone growth. Eur. J. Clin. Nutr. 48(Suppl. 1):S150-158.
20. Peters, K., D. Ornitz, S. Werner, and L. Williams. 1993. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev. Biol. 155:423-430.
21. Peters, K. G., S. Werner, G. Chen, and L. T. Williams. 1992. Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 114:233-243.
22. Ponseti, I. V. 1970. Skeletal growth in achondroplasia. J. Bone Jt. Surg. Am. Vol. 52:701-716.
23. Ponseti, I. V. 1988. Bone formation in achondropiasia. Basic Life Sci. 48: 109-122.
24. Raffioni, S., Y. Z. Zhu, R. A. Bradshaw, and L. M. Thompson. 1998. Effect of transmembrane and kinase domain mutations on fibroblast growth factor receptor 3 chimera signaling in PC12 cells. A model for the control of receptor tyrosine kinase activation J. Biol. Chem. 273:35250-35259.
25. Robertson, S. C., A. N. Meyer, K. C. Hart, B. D. Galvin, M. K. Webster, and D. J. Donoghue. 1998. Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain. Proc. Natl. Acad. Sci. USA 95:4567-4572.
26. Rossant, J., B. Ciruna, and J. Partanen. 1997. FGF signaling in mouse gastrulation and anteroposterior patterning. Cold Spring Harbor Symp. Quant. Biol. 62:127-133.
27. Rousseau, F., J. Bonaventure, M. L. Legeai, A. Pelet, J. M. Rozet, P. Maroteaux, M. M. Le, and A. Munnich. 1994. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371:252-254.
28. Rousseau, F., V. el Ghouzzi, A. L. Delezoide, L. Legeai-Mallet, M. Le Merrer, A. Munnich, and J. Bonaventure. 1996. Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). Hum. Mol. Genet. 5:509-512.
29. Segev, O., I. Chumakov, Z. Nevo, D. Givol, L. Madar-Shapiro, Y. Sheinin, M. Weinreb, and A. Yayon. Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3G380R transgenic mice. Hum. Mol. Genet., in press.
30. Shiang, R., L. M. Thompson, Y. Z. Zhu, D. M. Church, T. J. Fielder, M. Bocian, S. T. Winokur, and J. J. Wasmuth. 1994. Mutations in the transmembrane domain of FGFR3 cause the most commun genetic form of dwarfism, achondroplasia. Cell 78:335-342.
31. Sorkin, A., K. Helin, C. M. Waters, G. Carpenter, and L. Beguinot. 1992. Multiple autophosphorylation sites of the epidermal growth factor receptor are essential for receptor kinase activity and internalization. Contrasting significance of tyrosine 992 in the native and truncated receptors. J. Biol. Chem. 267:8672-8678.
32. Sorkin, A., C. Waters, K. A. Overholser, and G. Carpenter. 1991. Multiple autophosphorylation site mutations of the epidermal growth factor receptor. Analysis of kinase activity and endocytosis. J. Biol. Chem. 266:8355-8362.
33. Sorokin, A., M. Mohammadi, J. Huang, and J. Schlessinger. 1994. Internalization of fibroblast growth factor receptor is inhibited by a point mutation at tyrosine 766. J. Biol. Chem. 269:17056-17061.
34. Tavormina, P. L., R. Shiang, L. M. Thompson, Y. Z. Zhu, D. J. Wilkin, R. S. Lachman, W. R. Wilcox, D. L. Rimoin, D. H. Cohn, and J. J. Wasmuth. 1995. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat. Genet. 9:321-328.
35. Thompson, L. M., S. Raffioni, J. J. Wasmuth, and R. A. Bradshaw. 1997. Chimeras of the native form or achondroplasia mutant (G375C) of human fibroblast growth factor receptor 3 induce ligand-dependent differentiation of PC12 cells. Mol. Cell. Biol. 17:4169-4177.
36. Ullrich, A., and J. Schlessinger. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212.
37. Webster, M. K., P. Y. D'Avis, S. C. Robertson, and D. J. Donoghue. 1996. Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II. Mol. Cell. Biol. 16:4081-4087.
38. Webster, M. K., and D. J. Donoghue. 1996. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 15:520-527.
39. Webster, M. K., and D. J. Donoghue. 1997. FGFR activation in skeletal disorders: too much of a good thing. Trends Genet. 13:178-182.
40. Weiner, D. B., J. Liu, J. A. Cohen, W. V. Williams, and M. I. Greene. 1989. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature 339:230-231.
41. Wilkie, A. O., K. G. Morriss, E. Y. Jones, and J. K. Heath. 1995. Functions of fibroblast growth factors and their receptors. Curr. Biol. 5:500-507.
42. Wuechner, C., A. C. Nordqvist, A. Winterpacht, B. Zabel, and M. Schalling. 1996. Developmental expression of splicing variants of fibroblast growth factor receptor 3 (FGFR3) in mouse. Int. J. Dev. Biol. 40:1185-1188.